Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

PCDHGA5 Inhibitors

PCDHGA5 inhibitors constitute a specialized class of chemical compounds designed to selectively modulate the activity of the protocadherin gamma subfamily A member 5 (PCDHGA5) protein. Protocadherins are integral components of cell adhesion machinery, playing essential roles in diverse biological processes, particularly within the nervous system. PCDHGA5, belonging to the gamma subfamily, exhibits a specific expression pattern in neural tissues, emphasizing its involvement in neuronal development, synaptic connectivity, and overall neural circuit formation. The inhibitors developed for PCDHGA5 possess a unique chemical structure, enabling them to interact selectively with specific binding sites on the PCDHGA5 protein, thereby influencing its molecular activities at the cellular level.

The mechanism of action of PCDHGA5 inhibitors involves disrupting the normal functioning of the PCDHGA5 protein, potentially influencing cellular processes such as neuronal cell adhesion, axon guidance, and synapse formation. The precision in the design of these inhibitors ensures a high level of specificity, minimizing unintended effects on other closely related protocadherins. As researchers delve into the intricacies of neural development and cellular adhesion, PCDHGA5 inhibitors serve as valuable tools, allowing for the exploration of the intricate signaling cascades and molecular interactions involving PCDHGA5. The study of this chemical class contributes to a deeper understanding of the role played by PCDHGA5 in cellular physiology, offering insights into its potential functions within the complex networks that govern neural circuit formation and synaptic plasticity.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor may lead to demethylation of gene promoters, potentially affecting the expression of various genes, including PCDHGA5.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Similar to 5-Azacytidine, decitabine can cause hypomethylation of DNA and may alter the expression of genes such as PCDHGA5.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Vorinostat is a histone deacetylase inhibitor, which can lead to changes in chromatin structure and affect gene expression.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$214.00
$622.00
1
(1)

Romidepsin, another histone deacetylase inhibitor, may impact gene expression by altering chromatin accessibility.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A is also a histone deacetylase inhibitor that could modify the expression of genes by affecting chromatin structure.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

Entinostat is a selective histone deacetylase inhibitor that can influence gene expression profiles, possibly including PCDHGA5.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG108 is a DNA methyltransferase inhibitor that may prevent methylation of the PCDHGA5 gene promoter, potentially increasing its expression.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$126.00
$278.00
$984.00
3
(1)

Zebularine is a cytidine analog that can be incorporated into DNA and inhibit DNA methylation, possibly affecting the expression of genes like PCDHGA5.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$210.00
$242.00
$1434.00
2
(1)

Mocetinostat is a histone deacetylase inhibitor which may change the expression of a range of genes by affecting chromatin dynamics.

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

Panobinostat is a potent histone deacetylase inhibitor that may broadly affect gene expression, potentially including PCDHGA5.